Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Spallarossa

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Molecular Diversity|July 22, 2022
Mono- and di-acylated imidazolidine-2-thione derivatives: synthesis, cytotoxicity evaluation and computational studiesAnna Scarsi, Marco Ponassi, Chiara Brullo, et al.
International Journal of Molecular Sciences|July 2, 2021
Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A PerspectiveEleonora Russo, Andrea Spallarossa, Bruno Tasso, et al.
Molecules (Basel, Switzerland)|February 25, 2023
Antimalarial Activity of Tri- and Tetra-Substituted Anilino PyrazolesMatteo Lusardi, Nicoletta Basilico, Chiara Rotolo, et al.
International Journal of Molecular Sciences|June 24, 2022
The Development of FAK Inhibitors: A Five-Year UpdateAndrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
Journal of Molecular Modeling|August 13, 2008
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and QSAR analysisElena Cichero, Giulia Menozzi, Andrea Spallarossa, et al.
Journal of Molecular Modeling|December 11, 2008
Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitorElena Cichero, Sara Cesarini, Andrea Spallarossa, et al.
Molecules (Basel, Switzerland)|January 26, 2021
<b>Bicyclic Basic Merbarone Analogues as Antiproliferative Agents</b>Andrea Spallarossa, Matteo Lusardi, Chiara Caneva, et al.
Chemmedchem|January 7, 2022
One-Pot Synthesis and Antiproliferative Activity of Highly Functionalized Pyrazole DerivativesMatteo Lusardi, Chiara Rotolo, Marco Ponassi, et al.
European Journal of Medicinal Chemistry|March 18, 2008
Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabantGiulia Menozzi, Paola Fossa, Elena Cichero, et al.
Molecules (Basel, Switzerland)|October 29, 2025
USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and TumorigenesisMatteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Molecular Diversity|July 22, 2022
Mono- and di-acylated imidazolidine-2-thione derivatives: synthesis, cytotoxicity evaluation and computational studiesAnna Scarsi, Marco Ponassi, Chiara Brullo, et al.
International Journal of Molecular Sciences|July 2, 2021
Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A PerspectiveEleonora Russo, Andrea Spallarossa, Bruno Tasso, et al.
Molecules (Basel, Switzerland)|February 25, 2023
Antimalarial Activity of Tri- and Tetra-Substituted Anilino PyrazolesMatteo Lusardi, Nicoletta Basilico, Chiara Rotolo, et al.
International Journal of Molecular Sciences|June 24, 2022
The Development of FAK Inhibitors: A Five-Year UpdateAndrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
Journal of Molecular Modeling|August 13, 2008
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and QSAR analysisElena Cichero, Giulia Menozzi, Andrea Spallarossa, et al.
Journal of Molecular Modeling|December 11, 2008
Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitorElena Cichero, Sara Cesarini, Andrea Spallarossa, et al.
Molecules (Basel, Switzerland)|January 26, 2021
<b>Bicyclic Basic Merbarone Analogues as Antiproliferative Agents</b>Andrea Spallarossa, Matteo Lusardi, Chiara Caneva, et al.
Chemmedchem|January 7, 2022
One-Pot Synthesis and Antiproliferative Activity of Highly Functionalized Pyrazole DerivativesMatteo Lusardi, Chiara Rotolo, Marco Ponassi, et al.
European Journal of Medicinal Chemistry|March 18, 2008
Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabantGiulia Menozzi, Paola Fossa, Elena Cichero, et al.
Molecules (Basel, Switzerland)|October 29, 2025
USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and TumorigenesisMatteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
Pageof 7